MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin

Oncotarget

Volumn 6, Issue 4, 2015, Pages 2277-2289

  Zhang, Xiang ^a   Cheng, Shu Li ^a   Bian, Ka ^a,b   Wang, Lei ^a   Zhang, Xiao ^a   Yan, Bo ^a   Jia, Lin Tao ^a   Zhao, Jing ^a   Gammoh, Noor ^c   Yang, An Gang ^a   Zhang, Rui ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Anoikis; Human hepatocellular carcinoma; ITGA5; microRNA 26a; Tumor metastasis

Indexed keywords

ALPHA5 INTEGRIN; MICRORNA 26A; PROTEIN KINASE B; MICRORNA; MIRN26A MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOIKIS; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; EMBRYO; ENZYME INACTIVATION; GENE OVEREXPRESSION; GENE SILENCING; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; METASTASIS; MOUSE; NONHUMAN; PREDICTION; PROTEIN FUNCTION; ANIMAL; BAGG ALBINO MOUSE; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HEP-G2 CELL LINE; LIVER TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANOIKIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HEP G2 CELLS; HUMANS; INTEGRIN ALPHA5; LIVER NEOPLASMS; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84922985286     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2956     Document Type: Article

References (44)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. CA Global cancer statistics. Cancer J Clin. 2011; 61: 69-90.
2. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011; 365: 1118-1127.
3. Yang P, Li QJ, Feng Y, Zhang Y, Markowitz GJ, Ning S, Deng Y, Zhao J, Jiang S, Yuan Y, Wang HY, Cheng SQ, Xie D and Wang XF. TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell. 2012; 22: 291-303.
4. Valastyan S and Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011; 147: 275-292.
5. Chaffer CL and Weinberg RA. A perspective on cancer cell metastasis. Science. 2011; 331: 1559-1564.
6. Paoli P, Giannoni E and Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta. 2013; 1833: 3481-3498.
7. Buchheit CL, Weigel KJ and Schafer ZT. Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression. Nat Rev Cancer. 2014; 14: 632-641.
8. Fofaria NM and Srivastava SK. Critical role of STAT3 in melanoma metastasis through anoikis resistance. Oncotarget. 2014; 5:7051-7064.
9. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol. 2004; 5:816-826.
10. Fu Y Feng MX, Yu J, Ma MZ, Liu XJ, Li J, Yang XM, Wang YH, Zhang YL, Ao JP, Xue F, Qin W, Gu J, Xia Q, and Zhang ZG. DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by a3β1 integrin-Rho GTPase signaling. Oncotarget. 2014; 5:6701-6715.
11. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116: 281-297.
12. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136: 215-233.
13. Calin GA and Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006; 6: 857-866.
14. Inui M, Martello G and Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 2010; 11: 252-263.
15. Negrini M, Gramantieri L, Sabbioni S and Croce CM. microRNA involvement in hepatocellular carcinoma. Anticancer Agents Med Chem. 2011; 11: 500-521.
16. Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, Ogata H, Karin M, Struhl K, Hadzopoulou-Cladaras M and Iliopoulos D. An HNF4a-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell. 2011; 147: 1233-1247.
17. Zho HC, Fang JH, Luo X, Zhang L, Yang J, Zhang C and Zhuang SM. Downregulation of microRNA-100 enhances the ICMT-Rac1 signaling and promotes metastasis of hepatocellular carcinoma cells. Oncotarget. 2014 Oct 18. pii: 2601. [Epub ahead of print].
18. Wang L, Zhang X, Jia LT, Hu SJ, Zhao J, Yang JD, Wen WH, Wang Z, Wang T, Zhao J, Wang RA, Meng YL, Nie YZ, et al. c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma. Hepatology. 2014; 59: 1850-1863.
19. Saner S, Bullinger L, Klapproth K, Fiedler K, Kestler HA, Barth TF, Möller P, Stilgenbauer S, Pollack JR and Wirth T. MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood. 2008; 112:4202-4212.
20. Koh CM, Iwata T, Zheng Q, Bethel C, Yegnasubramanian S and De Marzo AM. Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptionalmechanisms. Oncotarget. 2011; 2:669-683.
21. Salvtori B, Iosue I, Djodji Damas N, Mangiavacchi A, Chiaretti S, Messina M, Padula F, Guarini A, Bozzoni I, Fazi F and Fatica A. Critical Role of c-Myc in Acute Myeloid Leukemia Involving Direct Regulation of miR-26a and HistoneMethyltransferase EZH2. Genes Cancer. 2011; 2:585-592.
22. Zeitls LR, Acharya A, Shi G, Chivukula D, Chivukula RR, Anandam JL, Abdelnaby AA, Balch GC, Mansour JC, Yopp AC, Richardson JA and Mendell JT. Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis. Genes Dev. 2014 Nov 13. pii: gad.250951.114. [Epub ahead of print].
23. Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS., Croce CM, Qin LX, Man K, Lo CM, et al. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med. 2009; 361: 1437-1447.
24. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA., Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR and Mendell JT. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009; 137: 1005-1017.
25. Yang X, Liang L, Zhang XF, Jia HL, Qin Y, Zhu XC, Gao XM, Qiao P, Zheng Y, Sheng YY, Wei JW, Zhou HJ, Ren N, et al. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology. 2013; 58: 158-170.
26. Yang X, Zhang XF, Lu X, Jia HL, Liang L, Dong QZ, Ye QH, Qin LX. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway. Hepatology. 2014; 59: 1874-1885.
27. Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, Beitsch PD, Leitch M, Hoover S, Euhus D, Haley B, Morrison L, Fleming TP, et al. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res. 2004; 10: 8152-8162.
28. Wurdinger T, Badr C, Pike L, de Kleine R, Weissleder R, Breakefield XO and Tannous BA. A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Methods. 2008; 5: 171-173.
29. Bovenberg MS, Degeling MH and Tannous BA. Enhanced Gaussia luciferase blood assay for monitoring of in vivo biological processes. Anal Chem. 2012; 84: 1189-1192.
30. Zhong X and Rescorla FJ. Cell surface adhesion molecules and adhesion-initiated signaling: understanding of anoikis resistance mechanisms and therapeutic opportunities. Cell Signal. 2012; 24: 393-401.
31. Guo H, Ingolia NT, Weissman JS and Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010; 466: 835-840.
32. Qin L, Chen X, Wu Y, Feng Z, He T, Wang L, Liao L and Xu J. Steroid receptor coactivator-1 upregulates integrin a5 expression to promote breast cancer cell adhesion and migration. Cancer Res. 2011; 71: 1742-1751.
33. Zeng Q, Chen S, You Z, Yang F, Carey TE, Saims D and Wang CY. Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B. J Biol Chem. 2002; 277: 25203-25208.
34. Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E and Peeper DS. Suppression of anoikis and induction of etastasis by the neurotrophic receptor TrkB. Nature. 2004; 430: 1034-1039.
35. Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T and Holland EC. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev. 2009; 23: 1327-1337.
36. Zhang J, Han C and Wu T. MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin. Gastroenterology. 2012; 143: 246-256.
37. Zou ZJ, Fan L, Wang L, Xu J, Zhang R, Tian T, Li JY and Xu W. miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylation. Oncotarget. 2014 Oct 24. pii: 2626. [Epub ahead of print].
38. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW and Hayes DF. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004; 351: 781-791.
39. Lucci A, Hall CS, Lodhi AK, Bhattacharyya A, Anderson AE, Xiao L, Bedrosian I, Kuerer HM and Krishnamurthy S. Circulating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol. 2012; 13: 688-695.
40. Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, Brannigan BW, Kapur R, Stott SL, et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014; 158: 1110-1122.
41. Yu X, Cohen DM and Chen CS. miR-125b is an adhesion-regulated microRNA that protects mesenchymal stem cells from anoikis. Stem Cells. 2012; 30: 956-964.
42. Haenssen KK, Caldwell SA, Shahriari KS, Jackson SR, Whelan KA, Klein-Szanto AJ and Reginato MJ. ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells. J Cell Sci. 2010; 123: 1373-1382.
43. Wu L, Bernard-Trifilo JA, Lim Y, Lim ST, Mitra SK, Uryu S, Chen M, Pallen CJ, Cheung NK, Mikolon D, Mielgo A, Stupack DG and Schlaepfer DD. Distinct FAK-Src activation events promote alpha5beta1 and alpha4beta1 integrin-stimulated neuroblastoma cell motility. Oncogene. 2008; 27: 1439-1448.
44. Desgrosellier JS and Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010; 10: 9-22.